ArticleCell cycle (Georgetown, Tex.)2012

Retained platinum uptake and indifference to p53 status make novel transplatinum agents active in platinum-resistant cells compared to cisplatin and oxaliplatin.

Robert F Murphy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.